AHF to President Trump: Save Florida's AIDS Drug Assistance Program!

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) today called on President Donald Trump to intervene and save the lives of thousands of people living with HIV who depend on the federally funded AIDS Drug Assistance Program (ADAP).

"The Florida Department of Health has unilaterally decided that on March 1 it will reduce ADAP eligibility for 16,000 people living with HIV in the state who depend on ADAP for life-saving treatment," said AHF Southern Bureau Chief Tracy Jones. "For ADAP to work, states must also contribute their share of funds along with rebates from prescription drug manufacturers. Even though many Florida state legislators want to fully fund the state's share of ADAP, the Department of Health announced that on March 1, it will terminate ADAP coverage for 16,000 people living with HIV. And in addition, the Department said it will no longer pay for the most prescribed HIV drug necessary to suppress the virus that causes AIDS."

"President Trump, in your first term, you started a program called 'Ending the Epidemic' whose goal is to end the HIV epidemic by 2030. Florida is critical to that goal, and these cuts would move us backward. Without an immediate reversal of this decision, next week thousands of Floridians will be kicked off a program that keeps them alive," added Jones. "Mr. President, don't let Florida become the first state to undermine your legacy on HIV."

AIDS Healthcare Foundation (AHF), the world’s largest HIV/AIDS healthcare organization, provides cutting-edge medicine and advocacy to more than 2.8 million individuals across 50 countries, including the U.S. and in Africa, Latin America/Caribbean, the Asia/Pacific Region, and Eastern Europe. In January 2025, AHF received the MLK, Jr. Social Justice Award, The King Center’s highest recognition for an organization leading work in the social justice arena. To learn more about AHF, visit us online at AIDShealth.org, find us on Facebook, and follow us on Instagram, Twitter, and TikTok.